Baxter International Inc
Change company Symbol lookup
Select an option...
BAX Baxter International Inc
APGN Apexigen Inc
NSRGY Nestle SA
WE WeWork Inc
NOK Nokia Oyj
HLNE Hamilton Lane Inc
SAL Salisbury Bancorp Inc
MFON Mobivity Holdings Corp
XPEV Xpeng Inc
ENVX Enovix Corp
Go

Health Care : Health Care Equipment & Supplies | Mid Cap Blend

Baxter International Inc. through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s segments include Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia-Pacific), and Hillrom. The Americas, EMEA and APAC segments provide a portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices and by patients at home under physician supervision.

Price: Delayed
$61.84

Day's Change: 0.00 (0.00%)

Bid: --

Ask: --

B/A Size: --

Day's High: --

Day's Low: --

Volume (Light) Today's volume of 199 shares is on pace to be much lighter than BAX's 10-day average volume of 2,978,170 shares.: 199

July 28, 2022
7:15 am ET	Baxter Reports Second-Quarter 2022 Results Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2022. "Baxter's diverse, durable portfolio of essential healthcare products powers our business, even amid unprecedented macroeconomic...(BusinessWire)
July 27, 2022
2:30 pm ET	Orhub's Ryan Fernan Becomes Head Of Pur Biologics, Leading Regenerative Therapeutic Efforts A proven industry leader and executive, Ryan Fernan, will help ORHub advance Ortho-Spine technology beyond current limitations. IRVINE, CA / ACCESSWIRE / July 27, 2022 / ORHub, Inc. (OTC Pink:ORHB) officially kicks off the acquisition of PUR...(Accesswire)
July 12, 2022
5:01 pm ET	Baxter Declares Quarterly Dividend Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on October 3, 2022, to shareholders of...(BusinessWire)
June 27, 2022
8:00 am ET	Baxter Details Progress Toward Environmental, Social and Governance (ESG) Priorities in Annual Corporate Responsibility Report Baxter International Inc. (NYSE:BAX), a global medtech leader, today released its 2021 Corporate Responsibility Report, demonstrating how the company is progressing toward its 2030 Corporate Responsibility Commitment and Goals. The report highlights...(BusinessWire)
June 08, 2022
4:15 pm ET	Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2022 financial results on Thursday, July 28, 2022 at 7:30 a.m. Central Time. To participate in this conference call please...(BusinessWire)
June 02, 2022
4:15 pm ET	Baxter to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 43rd Annual Global Healthcare Conference on Tuesday, June 14, 2022. Jose (Joe) Almeida, Baxter's chairman and chief executive officer, is scheduled to...(BusinessWire)
May 25, 2022
9:00 am ET	Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference Baxter International Inc. (NYSE:BAX), a global medtech leader, will showcase its ongoing trajectory of transformation and growth at its 2022 Investor Conference, being held today in Glenview, Ill. The company's executive leadership team will...(BusinessWire)

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and